Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 4, 2004, Pages 603-607

  Fan, Yue Zu ^a   Fu, Jin Ye ^b   Zhao, Ze Ming ^a   Chen, Cun Qiu ^a  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^b People's Hospital of Pudong New Area   (China)

Author keywords

Cell culture; Cell proliferation; Gallbladder neoplasm; Immunohistochemistry; Ki 67; Norcantharidin; Proliferating cell nuclear antigen

Indexed keywords

BIOTIN; CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; NORCANTHARIDIN; STREPTAVIDIN; TETRAZOLIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; GALLBLADDER CARCINOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BICYCLO COMPOUNDS, HETEROCYCLIC; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PROLIFERATING CELL NUCLEAR ANTIGEN; STAINING AND LABELING;

EID: 9444230462     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167-176.
2. Bartlett DL. Gallbladder cancer. Semin Surg Oncol 2000;19: 145-155.
3. Lazcano-Ponce EC, Miquel JF, Munoz N. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001;51:349-364.
4. Muratore A, Polastri R, Capussotti L. Radical surgery for gallbladder cancer: current options. Eur J Surg Oncol 2000; 26: 438-443.
5. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000;232:557-569.
6. Kondo S, Nimura Y, Hayakawa N. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg 2000;87:418-422.
7. Fu JY, Fan YZ. Chemotherapy for gallbladder carcinoma - present and perspective. J Tongji University Med 2001;22:73-75.
8. Houry S, Haccart V, Huguier M, Schlienger M. Gallbladder cancer: role of radiation therapy. Hepatogastroenterology 1999; 46:1578-1584.
9. Kresl JJ, Schild SE, Henning GT. Adjuvant external beam radiation therapy with concurrent chemotherapy in the treatment of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 2002; 52:167-175.
10. Todoroki T. Chemotherapy for gallbladder carcinoma - a surgeon's perspective. Hepatogastroenterology 2000;47:948-955.
11. Misra NC, Misra S, Sharma ID. Newer chemotherapy protocols in advanced cancer gallbladder. Proceeding of the XVth Asia Pacific Cancer Conference, Chennai. 1999;94:12-15.
12. Misra S, Misra NC, Chaturvedi A. Epidemiology, aetiology and multimodal therapy in cancer gallbladder with special reference to radical surgery and newer chemotherapy protocols: A prospective study of 631 patients. Proceedings of the American Society of Clinical Oncology Pan Asia Cancer Conference, New Delhi, India, 2002;85-87.
13. Fan YZ, Fu JY, Zhao ZM, Chun CQ. Influence of norcantharidin on proliferation and apoptosis of GBC-SD cell lines of human gallbladder carcinoma. J Shanghai Med 2003;26:1-4.
14. Fan YZ, Fu JY, Zhao ZM, Chen CQ. The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism. Zhonghua Zhongliu Zazhi 2004;26:271-274.
15. Wang GS. Medical uses of Mylabris in ancient China and recent studies. J Ethnopharmacol 1989;26:147-162.
16. Liu J, Gao J, Liu X. Advances in the study of Cantharidin and its derivatives. Zhong Yao Cai 2003;26:453-455.
17. Williams LA, Moller W, Merisor E, Kraus W, Rosner H. In vitro anti-proliferation/cytotoxic activity of cantharidin (Spanish Fly) and related derivatives. West Indian Med J 2003;52:10-13.
18. Ho YP, To KK, Au-Yeung SC, Wang X, Lin G, Han X. Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety. J Med Chem 2001;44: 2065-2068.
19. McCluskey A, Ackland SP, Bowyer MC, Baldwin ML, Garner J, Walkom CC, et al. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines. Bioorg Chem 2003;31:68-79.
20. Mack P, Ha XF, Cheng LY. Efficacy of intra-arterial norcantharidin in suppressing tumor 14C-labelled glucose oxidative metabolism in rat Morris hepatoma. HPB; Surg 1996;10:65-72.
21. Yang EB, Tang WY, Zhang K, Cheng LY, Mack PO. Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. Cancer Lett 1997;117:93-98.
22. Yi SN, Wass J, Vincent P, Iland H. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro. Leuk Res 1991;15:883-886.
23. Kok SH, Hong CY, Kuo MY, Lee CH, Lee JJ, Lou IU, et al. Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes. Oral Oncol 2003;39:19-26.
24. Sun ZX, Ma QW, Zhao TD, Wei YL, Wang GS, Li JS. Apoptosis induced by norcantharidin in human tumor cells. World J Gastroenterol 2000;6:263-265.
25. Hong CY, Huang SC, Lin SK, Lee JJ, Chueh LL, Lee CH. Norcantharidin-induced post-G(2)/M apoptosis is dependent on wild-type p53 gene. Biochem Biophys Res Commun 2000;276:278-285.
26. Chen YN, Chen JC, Yin SC, Wang GS, Tsauer W, Hsu SF, et al. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Int J Cancer 2002;100:158-165.
27. Chen YN, Cheng CC, Chen JC, Tsauer W, Hsu SL. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells. Br J Pharmacol 2003;140: 461-470.
28. Peng F, Wei YQ, Tian L, Yang L, Zhao X, Lu Y, et al. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J Cancer Res Clin Oncol 2002;128:223-230.
29. Liu XH, Blazsek I, Comisso M, Legras S, Marion S, Quittet P, et al. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. Eur J Cancer 1995;31A:953-963.
30. Hart ME, Chamberlin AR, Walkom C, Sakoff JA, McCluskey A. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. Bioorg Med Chem Lett 2004;14:1969-1973.
31. Baba Y, Hirukawa N, Tanohira N, Sodeoka M. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin). J Am Chem Soc 2003;125:9740-9749.
32. Hall PA. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasm. J Pathol 1990;162:285.
33. Takasaki Y, Kogure T, Takeuchi K. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. J Immunol 2001;166: 4780-4787.
34. Getdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710.
35. Okabe M, Inagaki H, Murase T, Inoue M, Nagai N, Eimoto T. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland. Modern Pathol 2001;14:1008-1014.